Biosimilar drugs: 2020 business records

(ANSA) – Rome, September 22 – the market of biotechnology Biosimilar, drugs drugs are similar but not identical to the original molecule, in 2011 was worth around $ 600 million, but by 2020 could be up to 25 billion dollars. He explains, speaking at the 4th Conference organized by Assogenerici in Rome, Antonio Iervolino, Ims Consulting Group. “They remain a niche market, less than 1% of generic drugs, says the expert, but in the coming years should have a significant growth”. All rights reserved